A new bioassay for measuring the strength of IL-6/STAT3 signal inhibition by tocilizumab in patients with rheumatoid arthritis

BACKGROUND: Interleukin-6 (IL-6) transduces signals via phosphorylation of STAT3 (pSTAT3). Tocilizumab (TCZ) is an IL-6 receptor blocker, which, when administered intravenously every 4 weeks, efficiently ameliorates rheumatoid arthritis (RA). Since IL-6 signal strength varies among patients with RA,...

全面介紹

Na minha lista:
書目詳細資料
發表在:Arthritis Res Ther
Main Authors: Saito, Shuntaro, Suzuki, Katsuya, Yoshimoto, Keiko, Kaneko, Yuko, Matsumoto, Yoshihiro, Yamaoka, Kunihiro, Takeuchi, Tsutomu
格式: Artigo
語言:Inglês
出版: BioMed Central 2017
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5645925/
https://ncbi.nlm.nih.gov/pubmed/29041951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-017-1434-6
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍